Sees FY25 revenue $16.8B-$17.4B, consensus $16.42B Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on TEVA: Teva reports Q4 EPS 71c, consensus 70c Options Volatility and Implied Earnings Moves Today, January 29, 2025 Alvotech, Teva announce FDA accepts BLA for AVT05 Is TEVA a Buy, Before Earnings? Teva price target raised to $30 from $28 at UBS Disclaimer & DisclosureReport an Issue
